Stanley Nelson, MD has been awarded $100,000 from Parent Project Muscular Dystrophy to examine the genomes of boys who are either very mildly or very severly affected with Duchenne muscular dystrophy, to identify changes in genes other than dystrophin that may affect the disease's course. | More Information |
|
|
The American Joint Committee on Cancer (AJCC) recently named Mahul B. Amin, MD, FCAP as Editor-In-Chief of the upcoming eighth edition of the AJCC Cancer Staging Manual. | More Information
|
|
|
Drs. Faramarz Naeim, MD; Nagesh Rao, PhD; Sophie Song, MD, Phd; and Wayne Grody, MD, PhD have authored the Atlas of Hematopathology: Morphology, Immunophenotype, Cytogenetics and Molecular Approaches, the definitive diagnostic atlas of the diseases of the hematopoietic system. | More Information
|
|
|
Congratulations to Michael Teitell, MD, PhD, who has been appointed Lya and Harrison Latta Chair in Pathology. The purpose of the Chair is to advance the discipline of Pathology through the interdisciplinary translation of basic biology to the prevention and treatment of disease.
|
|
|
Congratulations to Wayne Grody, MD, PhD. Dr. Grody is the recipient of the 2015 UCLA Golden Apple Award, Intercampus Medical Genetics Training Program
|
|
|
Congratulations to Elena Stark, MD, PhD. Dr. Stark is the recipient of the 2015 UCLA Golden Apple Award in Teaching Excellence.
|
|
|

Congratulations to Drs. Scott Binder, Alistair Cochran, Galen Cortina, Charles Lassman, Sheeja Pullarkat, Jonathan Said and Hanlin Wang, voted Best Doctors 2013. | More Information
|
|
Clinical Exome Sequencing Presentation
View Stanley Nelson, MD's presentation of "Clinical Exome Sequencing at UCLA | UCLA Pathology & Laboratory Medicine. | View Video
|
|
Gregory Fishbein, MD Recipient of 2013 Daljit S. and Elaine Sarkaria Fellowship
First established in academic year 2004/2005, the Fellowship is awarded annually to recognize an outstanding trainee committed to disease research and clinical innovation. | Pathology Profile - Greg Fishbein
|
|
Researchers Discover Molecular Mechanism for Lethal form of Prostate Cancer
Findings published in the journal Endrocrine-Related Cancer demonstrate that an aggressive form of prostate cancer is a totally different disease than conventional prostate cancer. | More Information
|
|
Dr. Samuel French to receive 2014 Gold-Headed Cane Award
Congratulations to Samuel French, MD, who will be awarded the prestigeous 2014 American Society for Investigative Pathology Gold-Headed Cane Award for recognition of long-term contributions to pathology. | More Information
|
|
UCLA Enters Landmark Arrangements in China
UCLA Department of Path & Lab will be integral to landmark arrangements between UCLA and the Cancer Center Hospital/Institute, Chinese Academy of Medical Sciences (CAMS) | More Information
|
|
TPCL Receives Accreditation from College of American Pathologists
Sarah Dry was congratulated for the excellence of services being provided in the Translational Pathology Core Laboratory - UCLA Biorepository. | More Information
|
|
Jonathan Wisco to be awarded 2013 Besmajian Award
The American Association of Anatomists' 2013 Basmajian Award for Excellence in Teaching, Research & Scholarship will be presented to Jonathan Wisco this April. | More Information
|
|
Scientists find drug that may help in fight against duchenne muscular dystrophy
UCLA Scientists, including Drs. Stanley Nelson and Carrie Miceli, have identified a drug already approved by the FDA, that provides a powerful boost to therapy now being tested in clinical trials Read Article>>
|
|
Neuropathology: A Reference Text of CNS Pathology
Drs. Harry Vinters and William Yong of the Department of Path & Lab are among the authors of this newly-published, definitive reference text, now in its third edition.
|
|
Jianyu Rao, MD, published in ModernHealthcare.com
October 2012 - UCLA, Pathology & Lab Medicine's Dr. Jianyu Rao, MD conceived the idea for a telepathology program helping international telemedicine become a growing force for U.S. hospitals ModernHealthcare.com>>
|
|
David Chia PhD and Lee Goodglick, PhD, published in the New England Journal of Medicine
October 2012 - David Chia, PhD and Lee Goodglick, PhD, were recently published in the New England Journal of Medicine for work titled, "Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma" NEJM.org>>
|
|
Elaine Reed, PhD wins ASHI Rose Payne Distinguished Scientist Award
Dr. Reed, Director of the UCLA Immunogenetics Center, was awarded this top honor in Immunogenetics in recognition of her outstanding contributions to the field. Rose Payne was a pioneer in the field of immunogenetics, and Dr. Reed is one of only a handful of women who have ever been bestowed this distinguished award in its 28-year history. The UCLA Department of Pathology & Laboratory Medicine congratulates Dr. Reed for this outstanding achievement! Read more>>
|
|
Sarah Dry, MD Among Recipients of $2 million NIH Grant
The UCLA Department of Pathology and Laboratory Medicine congratulates Dr. Dry and her two UCSF colleagues who were recently awarded a $2 million NIH Supplemental Grant over a three year period - representing the first potential step to creating an integrated UC biorepository network. Read more>>
|
|
|

UCLA scientists discover 'missing link' between blood stem cells, immune system
UCLA researchers have discovered a type of cell that is the "missing link" between bone marrow stem cells and all the cells of the human immune system, a finding that will lead to a greater understanding of how a healthy immune system is produced and how disease can lead to poor immune function. The research was done using human bone marrow, which contains all the stem cells that produce blood during post-natal life. Read more>>
|
|
Disease that stunts infants' growth traced to same gene that makes cells grow too fast
UCLA geneticists have identified the mutation responsible for IMAGe syndrome, a rare disorder that stunts infants' growth. The twist? The mutation occurs on the same gene that causes Beckwith-Wiedemann syndrome, which makes cells grow too fast, leading to very large children. Published in the May 27 edition of the journal Nature Genetics, the UCLA findings could lead to new ways of blocking the rapid cell division that allows tumors to grow unchecked. The discovery also offers a new tool for diagnosing children with IMAGe syndrome, which until now has been difficult to identify accurately. Read more>>
|
|
Exome sequencing offers diagnostic clarity that can guide care decisions
Gene sequencing capabilities have advanced impressively over the past decade and the technology is beginning to have a significant impact as a diagnostic tool. In 2001, the first draft of the human genome was sequenced after a 10-year effort that cost about $3 billion. By 2007, the first individual genome sequence was published. It took about 6 months and cost about $4 million. Today, next generation sequencing tools make it possible to sequence the protein-coding portion of a patient's genome - and that of both parents - in a few weeks at a cost of about $6,500. Read more>>
|
|
Clinical Exome Takes Off: UCLA Launches Dx Test
May 2012 - As exome sequencing quickly becomes the method of choice for diagnosing rare conditions, a number of academic groups and companies have launched tests in recent months and are reporting their first successes. The University of California, Los Angeles, is one of the newest groups to offer exome sequencing in a CLIA-certified laboratory. genomeweb Article
|
|
Nature Profiles New Sequencing Program
February 2012 - Nature recently published a profile of a new program at UCLA led by the Departments of Human Genetics, Pathology & Laboratory Medicine, and Pediatrics that that can sequence a patient's entire genome, sometimes leading to a life-changing diagnosis. Wayne Grody, MD, PhD, medical director of the program and a professor of pathology, human genetics and pediatrics was quoted. Nature Article
|
|